GALIMBERTI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 23.559
EU - Europa 13.485
AS - Asia 12.390
SA - Sud America 1.742
Continente sconosciuto - Info sul continente non disponibili 1.003
AF - Africa 310
OC - Oceania 33
Totale 52.522
Nazione #
US - Stati Uniti d'America 22.352
IT - Italia 4.388
SG - Singapore 3.937
SE - Svezia 2.896
CN - Cina 2.398
VN - Vietnam 2.386
DE - Germania 1.487
HK - Hong Kong 1.487
BR - Brasile 1.291
RU - Federazione Russa 1.207
CA - Canada 918
IE - Irlanda 771
GB - Regno Unito 610
BD - Bangladesh 493
FR - Francia 454
UA - Ucraina 372
IN - India 369
FI - Finlandia 232
ID - Indonesia 211
NL - Olanda 207
KR - Corea 187
AT - Austria 185
TR - Turchia 142
AR - Argentina 141
MX - Messico 139
ES - Italia 137
JP - Giappone 124
IQ - Iraq 116
PL - Polonia 106
ZA - Sudafrica 85
BE - Belgio 76
PK - Pakistan 75
DK - Danimarca 73
SA - Arabia Saudita 73
PH - Filippine 65
VE - Venezuela 65
CO - Colombia 63
EC - Ecuador 58
CH - Svizzera 55
MA - Marocco 50
PY - Paraguay 37
EG - Egitto 36
LT - Lituania 36
JM - Giamaica 34
UZ - Uzbekistan 34
CR - Costa Rica 33
MY - Malesia 32
AU - Australia 29
AE - Emirati Arabi Uniti 28
UY - Uruguay 28
CL - Cile 27
TN - Tunisia 27
GR - Grecia 26
JO - Giordania 26
KE - Kenya 26
ET - Etiopia 24
NP - Nepal 24
PT - Portogallo 23
CZ - Repubblica Ceca 22
RO - Romania 21
TH - Thailandia 20
AZ - Azerbaigian 19
IL - Israele 19
IR - Iran 19
PE - Perù 18
DZ - Algeria 16
NI - Nicaragua 16
KZ - Kazakistan 15
AL - Albania 11
BO - Bolivia 11
LB - Libano 11
OM - Oman 11
BG - Bulgaria 10
HN - Honduras 10
TT - Trinidad e Tobago 10
EE - Estonia 9
HU - Ungheria 9
NO - Norvegia 9
PS - Palestinian Territory 9
RS - Serbia 9
HR - Croazia 8
TW - Taiwan 8
BY - Bielorussia 7
GT - Guatemala 7
PA - Panama 7
SK - Slovacchia (Repubblica Slovacca) 7
SV - El Salvador 7
AO - Angola 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
SI - Slovenia 6
SY - Repubblica araba siriana 6
CI - Costa d'Avorio 5
EU - Europa 5
LV - Lettonia 5
MD - Moldavia 5
AM - Armenia 4
BB - Barbados 4
BW - Botswana 4
GA - Gabon 4
Totale 51.432
Città #
Ann Arbor 2.645
Ashburn 2.565
Singapore 2.326
Stockholm 1.910
San Jose 1.712
Milan 1.423
Hong Kong 1.414
Frankfurt am Main 858
Fairfield 844
Chandler 827
Dublin 750
Woodbridge 722
Ho Chi Minh City 707
Houston 590
New York 580
Toronto 577
Hanoi 573
Wilmington 549
Los Angeles 508
Dallas 462
Council Bluffs 457
Santa Clara 430
Beijing 352
Seattle 346
Jacksonville 336
Chicago 322
Hefei 318
Dearborn 307
Cambridge 289
Rome 259
Princeton 253
The Dalles 217
Buffalo 173
Shanghai 168
Seoul 165
Lauterbourg 160
Columbus 149
Boardman 145
São Paulo 145
Jakarta 138
Nanjing 134
Vienna 134
Moscow 133
Phoenix 130
Orem 114
Denver 105
Helsinki 103
Altamura 100
Atlanta 100
Lawrence 95
Tokyo 92
London 87
Montreal 87
Da Nang 82
Warsaw 79
Haiphong 77
Munich 77
Brooklyn 73
Naples 69
Turin 68
Nuremberg 61
San Diego 59
Figino 58
Brussels 57
Chennai 57
Ottawa 57
Lissone 56
Dong Ket 55
San Francisco 55
Monza 54
Washington 53
Lachine 52
Biên Hòa 48
Bologna 47
Florence 47
Baghdad 45
Nanchang 45
Philadelphia 45
Johannesburg 44
Newark 43
Guangzhou 42
Poplar 42
Boston 41
Hải Dương 41
Shenyang 41
Tianjin 41
Dhaka 40
Fremont 40
Manchester 39
Rio de Janeiro 39
Zurich 39
Amsterdam 38
Falls Church 38
Genoa 38
Ha Long 38
Jinan 38
Andover 37
Lappeenranta 37
Mexico City 37
Sesto San Giovanni 37
Totale 31.431
Nome #
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial 2.022
Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population 953
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 731
Thyroid Function Tests in Children and Adolescents with Trisomy 21: Definition of Syndrome-Specific Reference Ranges 516
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 510
Tracheostomy practice and timing in traumatic brain-injured patients: a CENTER-TBI study 503
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 495
Ventilation practices in acute brain injured patients and association with outcomes: the VENTIBRAIN multicenter observational study 489
The SIPI for measuring complexity in nursing care: Evaluation study 482
Carotid plaque echolucency increases the risk of stroke in carotid stenting: The imaging in carotid angioplasty and risk of stroke (ICAROS) study 463
Effect of Oral Hydration on External Cephalic Version at Term 456
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 452
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 448
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 445
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 434
Basket trials in very rare diseases: are they feasible? 432
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 431
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 426
Use of Shear Wave Elastography in the Sonographic Triage of Thyroid Nodules: Feasibility Study in a Series of Lesions Already Selected for Fine Needle Aspiration 418
BIVARIATE COPULA MODELS IN THE PRESENCE OF COMPLEX PATTERNS FOR THE SURROGATE ENDPOINT FOR A SURVIVAL TRUE ENDPOINT 412
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 404
Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study 402
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 397
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 385
Urinary Extracellular Vesicle Protein Profiles Discriminate Different Clinical Subgroups of Children with Idiopathic Nephrotic Syndrome 385
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 384
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 376
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 376
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome 372
Validation of a skewed surrogate endpoint for a time-to-event outcome: the use of a Zaga distribution 367
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 362
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 358
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 358
Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases 346
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 343
Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL 343
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 342
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 341
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 338
Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation 337
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 334
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 332
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 332
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 327
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 327
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 324
The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillation 324
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 321
Prevalence and timing of tracheostomy in traumatic brain injured patients: a secondary analysis from the CENTER-TBI study 320
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 319
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 319
Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T 317
Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study 316
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability 311
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 303
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 302
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 299
Development of new methods for the validation of non standard distributions for the surrogate endpoint for a time to event endpoint. 296
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 293
Robust non parametric one-sample tests for the analysis of recurrent events 292
Practice of ICP monitoring in acute brain‑injured patients: results from the Synapse‑ICU study 292
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor 290
Neurological Pupil Index and Intracranial Hypertension in Patients with Acute Brain Injury: A Secondary Analysis of the ORANGE Study 288
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 288
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome 288
Prescribing patterns of antithrombotic drugs to elderly patients with atrial fibrillation admitted to an acute geriatric unit 288
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 288
Using multiple timescale models for the evaluation of a time-dependent treatment 287
Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes-an analysis of CENTER-TBI data 285
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 285
Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases 283
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 282
MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis 281
Carotid plaque echolucency predicts the effectiveness of brain protection devices in carotid stenting: The ICAROS study 280
La qualita’ di vita nei pazienti neodializzati: due interventi di pre-dialisi a confronto 280
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial 278
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 278
Intracranial pressure management in acute brain‑injured patients: baseline characteristics of the Synapse‑ICU Centers ESICM LIVES 2020 277
A causal inference approach to compare leukaemia treatment outcome in the absence of randomization and with dependent censoring 277
The Neurological Pupil index for outcome prognostication in people with acute brain injury (ORANGE): a prospective, observational, multicentre cohort study 275
Association between serum values of C-reactive protein and cytokine production in whole blood of patients with Type 2 diabetes 275
Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy 275
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 274
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence 272
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 270
Long-term effects of bone marrow transplantation on dental status in children with leukaemia 268
Microwave ablation of hepatic tumors with a third generation system: Loco-regional efficacy in a prospective cohort study with intermediate term follow-up 268
Multiple sclerosis progression is not associated with birth timing in Italy 267
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 265
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 262
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 262
ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer 261
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 259
Multivariate permutation test to compare survival curves for matched data 259
Sample size calculation for recurrent events data in one-arm studies 257
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 256
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM 255
Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation 253
Percutaneous Microwave Ablation of Hepatic Tumors: Prospective Evaluation of Postablation Syndrome and Postprocedural Pain 252
A DNA damage response-like phenotype defines a third of colon cancers at onset 251
Totale 36.073
Categoria #
all - tutte 156.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.434


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.573 0 0 0 246 169 163 71 83 116 179 191 355
2022/20233.651 417 972 374 333 207 507 69 233 271 38 147 83
2023/20242.829 90 122 113 202 330 653 551 122 173 72 95 306
2024/20257.045 282 592 566 368 609 410 390 268 697 1.073 608 1.182
2025/202621.972 2.481 1.389 1.379 2.115 2.164 1.025 2.819 853 1.529 3.472 1.241 1.505
2026/20275.771 1.259 1.341 2.231 940 0 0 0 0 0 0 0 0
Totale 52.522